CN1226170A - 基于丙酸菌的免疫刺激剂的制备 - Google Patents
基于丙酸菌的免疫刺激剂的制备 Download PDFInfo
- Publication number
- CN1226170A CN1226170A CN97196768A CN97196768A CN1226170A CN 1226170 A CN1226170 A CN 1226170A CN 97196768 A CN97196768 A CN 97196768A CN 97196768 A CN97196768 A CN 97196768A CN 1226170 A CN1226170 A CN 1226170A
- Authority
- CN
- China
- Prior art keywords
- preparation
- propionibacteria
- solution
- agents based
- immunostimulating agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000003022 immunostimulating agent Substances 0.000 title claims abstract description 7
- 230000004151 fermentation Effects 0.000 claims abstract description 17
- 241000894006 Bacteria Species 0.000 claims abstract description 10
- 230000009849 deactivation Effects 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 7
- 230000000844 anti-bacterial effect Effects 0.000 claims description 6
- 230000003308 immunostimulating effect Effects 0.000 claims description 6
- 229960001438 immunostimulant agent Drugs 0.000 claims description 5
- 230000001413 cellular effect Effects 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 238000000855 fermentation Methods 0.000 abstract description 16
- 238000009630 liquid culture Methods 0.000 abstract 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 101100166829 Mus musculus Cenpk gene Proteins 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 239000012062 aqueous buffer Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 125000003180 beta-lactone group Chemical group 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 108010079058 casein hydrolysate Proteins 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000013530 defoamer Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
- C12N15/03—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19630230.7 | 1996-07-26 | ||
| DE19630230A DE19630230A1 (de) | 1996-07-26 | 1996-07-26 | Herstellung immunstimulierender Mittel auf Basis von Propionibakterien |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1226170A true CN1226170A (zh) | 1999-08-18 |
Family
ID=7800951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97196768A Pending CN1226170A (zh) | 1996-07-26 | 1997-07-14 | 基于丙酸菌的免疫刺激剂的制备 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0918530A1 (pt) |
| JP (1) | JP2000516922A (pt) |
| KR (1) | KR20000023629A (pt) |
| CN (1) | CN1226170A (pt) |
| AU (1) | AU3694897A (pt) |
| BR (1) | BR9710562A (pt) |
| CA (1) | CA2261991A1 (pt) |
| CZ (1) | CZ26799A3 (pt) |
| DE (1) | DE19630230A1 (pt) |
| NO (1) | NO990325D0 (pt) |
| PL (1) | PL331146A1 (pt) |
| SK (1) | SK5599A3 (pt) |
| TR (1) | TR199802777T2 (pt) |
| WO (1) | WO1998004275A1 (pt) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105876780A (zh) * | 2008-09-19 | 2016-08-24 | 雀巢产品技术援助有限公司 | 抗癌治疗中的免疫系统营养支持 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4521687B2 (ja) | 2002-06-21 | 2010-08-11 | ニューキャッスル イノベーション リミテッド | プロバイオティクス、プロピオニバクテリウム・イエンセニー７０２ |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3011461C2 (de) * | 1980-03-25 | 1986-10-30 | Dr. Madaus & Co, 5000 Köln | Verwendung von Propionibakterien |
| DE3817762A1 (de) * | 1988-05-26 | 1989-11-30 | Sanum Kehlbeck Gmbh & Co Kg | Immunstimulierendes mittel aus propionibakterien sowie verfahren zur herstellung desselben |
-
1996
- 1996-07-26 DE DE19630230A patent/DE19630230A1/de not_active Withdrawn
-
1997
- 1997-07-14 CA CA002261991A patent/CA2261991A1/en not_active Abandoned
- 1997-07-14 TR TR1998/02777T patent/TR199802777T2/xx unknown
- 1997-07-14 JP JP10508434A patent/JP2000516922A/ja active Pending
- 1997-07-14 AU AU36948/97A patent/AU3694897A/en not_active Abandoned
- 1997-07-14 EP EP97933674A patent/EP0918530A1/de not_active Withdrawn
- 1997-07-14 PL PL97331146A patent/PL331146A1/xx unknown
- 1997-07-14 CZ CZ99267A patent/CZ26799A3/cs unknown
- 1997-07-14 CN CN97196768A patent/CN1226170A/zh active Pending
- 1997-07-14 BR BR9710562A patent/BR9710562A/pt not_active Application Discontinuation
- 1997-07-14 SK SK55-99A patent/SK5599A3/sk unknown
- 1997-07-14 WO PCT/EP1997/003747 patent/WO1998004275A1/de not_active Application Discontinuation
-
1999
- 1999-01-08 KR KR1019997000078A patent/KR20000023629A/ko not_active Application Discontinuation
- 1999-01-25 NO NO990325A patent/NO990325D0/no not_active Application Discontinuation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105876780A (zh) * | 2008-09-19 | 2016-08-24 | 雀巢产品技术援助有限公司 | 抗癌治疗中的免疫系统营养支持 |
Also Published As
| Publication number | Publication date |
|---|---|
| TR199802777T2 (xx) | 1999-04-21 |
| NO990325L (no) | 1999-01-25 |
| CA2261991A1 (en) | 1998-02-05 |
| SK5599A3 (en) | 1999-07-12 |
| EP0918530A1 (de) | 1999-06-02 |
| DE19630230A1 (de) | 1998-01-29 |
| JP2000516922A (ja) | 2000-12-19 |
| PL331146A1 (en) | 1999-06-21 |
| WO1998004275A1 (de) | 1998-02-05 |
| NO990325D0 (no) | 1999-01-25 |
| CZ26799A3 (cs) | 1999-05-12 |
| AU3694897A (en) | 1998-02-20 |
| KR20000023629A (ko) | 2000-04-25 |
| BR9710562A (pt) | 1999-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102224237B (zh) | 使用β-丙内酯(BLP)进行最终灭活的细菌菌影(BG)生产方法 | |
| CN101977616B (zh) | 制备噬菌体混合物的方法以及该噬菌体混合物在抗生素抗性葡萄球菌治疗中的用途 | |
| BRPI0713215A2 (pt) | processo eficiente de produção e purificação de ácido hialurÈnico de elevado peso molecular e produto resultante | |
| WO1995004132A1 (en) | Process for the preparation and purification of high molecular weight hyaluronic acid | |
| CN110495611A (zh) | 一种提高海参营养保健功效的工艺 | |
| CN1082056A (zh) | 具有免疫刺激活性的葡聚糖 | |
| CN113142214B (zh) | 甲基营养型芽孢杆菌wswGH-10的抗菌蛋白的应用及分离纯化方法 | |
| NO159394B (no) | Fremgangsmaate for fremstilling av immunogene kapselformede polyosider fra kapselbakterier. | |
| CN1226170A (zh) | 基于丙酸菌的免疫刺激剂的制备 | |
| CA2073778C (en) | Enzyme treated bcg vaccine and process therefor | |
| CN102698259B (zh) | 一种鸡坏死性肠炎（a型）灭活疫苗制备方法 | |
| US20020114794A1 (en) | Staphylococcus aureus culture and preparation thereof | |
| JP2000093162A (ja) | 有胞子乳酸菌の培養方法 | |
| EP0073169A2 (en) | Immunogenic complex from N. gonorrhoeae | |
| MXPA99000959A (en) | Preparation of immunostimulating agents based on propionibacteria | |
| Shibl | Role of Staphylococcus aureus exfoliatin toxin in staphylococcal infections in mice | |
| RU2561467C1 (ru) | Способ получения препарата для повышения мясной и молочной продуктивности сельскохозяйственных животных (варианты) и препарат, полученный на его основе | |
| RU2158302C2 (ru) | Питательная среда для роста бифидо- и лактобактерий | |
| CN118207115A (zh) | 双歧杆菌的发酵方法和双歧杆菌发酵溶胞产物的制备方法 | |
| CN1222313C (zh) | 新型金葡菌素制剂及其制作方法 | |
| RU2089215C1 (ru) | Способ получения менингококкового серогруппы в липоолигосахарида | |
| CN1123636A (zh) | 一种微生态活菌饮料制品及其制造方法 | |
| RU2319502C1 (ru) | РАСТВОР ДЛЯ ИНЪЕКЦИЙ, РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pSX50, КОДИРУЮЩАЯ СИНТЕЗ РЕКОМБИНАНТНОГО ЧЕЛОВЕЧЕСКОГО АЛЬФА-2b ИНТЕРФЕРОНА, ШТАММ Escherichia coli SX50 - ПРОМЫШЛЕННЫЙ ШТАММ-ПРОДУЦЕНТ РЕКОМБИНАНТНОГО ЧЕЛОВЕЧЕСКОГО АЛЬФА-2b ИНТЕРФЕРОНА И СПОСОБ ПРОМЫШЛЕННОГО ПОЛУЧЕНИЯ ИНТЕРФЕРОНА АЛЬФА-2b | |
| Hanks | Behavior of leprosy bacilli in complex liquid media with highly available sources of nutrient and accessory substances | |
| RU2086246C1 (ru) | Способ получения энзимотерапевтического, противовирусного и иммуномодулирующего препарата и энзимотерапевтический, противовирусный и иммуномодулирующий препарат |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |